Neuronetics, Inc.

US$2.15As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:STIMHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (25.99%)
Div yield —
ROE (85.58%)
Medical Devices
Beta (5Y) 1.32
PE TTM —
TSR TTM (18.87%)
Mkt cap US$163.8M
ROIC (7.86%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.15
0.05%
(70.48%)
Hold 7|2|1|7|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.04
0.04
0.05
3.63%
1.44%
2.71%
19.35%
Revenue$M
8.624
8.835
9.289
9.637
15.72%
13.67%
17.37%
15.63%
Peers (US$163.8M)
Cap (US$)
PE
193.2M
64.62x
190.4M
—
160.0M
—
167.4M
133.1x
Capital
TTM
5Y
10Y
Leveragex
0.555
1.388
1.282
EBIT/Intx
1.518
3.683
2.877
Own earn%
(220.34)
91.76
82.03
Sh yield%
48.36
30.83
37.07
Owners
Insiders/Inst%
12.86
55.70
Short interest%
2.30
SBC / revenue%
5.30
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
19–27
$1 testx
—
Incr. ROIC%
14